Friday, August 12, 2022
66 F
Oxnard
More

    Latest Posts

    The Road to Tyranny by Don Jans

    Monoclonal Treatment Throttling By White House Spawns Workaround

    Sponsored - Job Posting

    We are a small but mighty business in Ventura, CA specializing in Civil/Agricultural Engineering and Land Surveying. Going strong for over 35 years. Looking for motivated team players for immediate hire. Candidates must have at least 3 years of experience in Civil Engineering, Land Surveying, and AutoCAD Civil 3D. Must want to grow with the company. For the right person, management potential. Wages will depend on experience. Benefits include paid holidays, matching retirement plan & much more. Send resumes to: [email protected]

    YCE, Inc. is an Equal Opportunity Employer. Tel: 805-650-6995www.YCEinc.com

    by Chris Bailey

    17 September 2021, Ventura County California

    The Biden administration, through the Health and Human Services Administration(HHS) is blocking majority Red states from using more monoclonal antibody (MA) treatment. The MA treatments, shown to be effective as a therapeutic fighting COVID-19, is used in Florida, Texas, Alabama, Mississippi, Georgia, and Louisiana to lower its hospitalization rates. Many Americans would have succumbed to a COVID-19 attack without the treatment.

    Under a “Public Health Emergency,” Biden has authorized an updated allocation of monoclonal antibody treatments through the U.S. Department of Health & Human Services. The new allocation format effectively throttles the use of more of the life saving treatment on a State by State basis. HHS will be the decider of weekly allocations. 

    GlaxoSmithKline (GSK) also makes a monoclonal antibodies product, Sotroimab is not on federal purchase orders affected by this new Biden Administration strategy to force Americans into the vaccinated group. Sotroimab became available in May 2021 under an EUA and recommended by the NIH for the Delta variant. States can use COVID-19 relief funds to make bulk purchases directly from GSK as HHS is not controlling Sotroimab under the new apportionment schedule.

    HHS, with this new order, will literally control access to antibody therapies for COVID-19 through the Federal purchasing programs. HHS is headed by Xavier Becarra, an extremely Leftist former Attorney General from California who is not a doctor. One area of expertise that presidents have not often tapped for the head of HHS is medicine. Only three secretaries have had medical training, and all have been Republicans. 

    Americans in every State should be aware of the Biden Administration’s decision to create this chokepoint to control the distribution of COVID-19 therapeutics.  Support access to fellow citizens, friends and family of all political persuasions for the overall health of all Americans. 

    Chris Bailey is a reporter-at-large of citizensjournal.us, a business owner, military veteran and longtime resident of Camarillo


    Get Citizensjournal.us Headlines free  SUBSCRIPTION. Keep us publishing – DONATE

    - Advertisement -

    1 COMMENT

    0 0 votes
    Article Rating
    Subscribe
    Notify of
    guest

    1 Comment
    Newest
    Oldest Most Voted
    Inline Feedbacks
    View all comments
    George Pattone
    George Pattone
    10 months ago

    Do you now see that this is NOT about the science, it’s NOT about people’s health…
    The depopulation theme is becoming more readily apparent by the day…

    Latest Posts

    advertisement

    Don't Miss

    Subscribe

    To receive the news in your inbox

    1
    0
    Would love your thoughts, please comment.x
    ()
    x